Skip to main content
logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.070
+0.050 (1.66%)
Aug 18, 2026, 1:05 PM EDT - Market open

Pyxis Oncology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
11.0413.8616.15---
Revenue Growth
291.42%-14.17%----
Gross Profit
8.6511.4715.67---
Operating Income
-89.71-81.85-65.57-80.42-123.48-69.72
Net Income
-88.73-79.62-77.33-73.79-120.72-75.98
Earnings Per Share
-1.40-1.28-1.32-1.85-3.65-8.95
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3366.86126.93119.3179.29274.74
Total Debt
17.8318.6720.221.3318.920.17
Net Cash (Debt)
15.1648.18106.7397.97160.37274.57
Net Cash Growth
-78.18%-54.85%8.95%-38.91%-41.59%3661.23%
Net Cash Per Share
0.240.781.832.464.8532.33

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-67.91-63.5-57.67-70.71-89.34-35.33
Capital Expenditures
-0.01-0.01-0.24-6.73-6.4-0.54
Free Cash Flow
-67.92-63.51-57.91-77.44-95.73-35.87
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
78.37%82.77%97.06%---
Operating Margin
-812.74%-590.60%-406.11%---
Pretax Margin
-793.84%-564.55%-492.35%---
Profit Margin
-803.83%-574.55%-478.95%---
FCF Margin
-615.32%-458.30%-358.66%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
22.825.175.75---